NYSE:RADRite Aid Stock Price, Forecast & News

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RAD shares have increased by 4.8% and is now trading at $14.81.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Rite Aid.

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020.
View our earnings forecast for Rite Aid.

Rite Aid Co. (NYSE:RAD) issued its earnings results on Thursday, June, 25th. The company reported ($0.04) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.38) by $0.34. The firm earned $6.03 billion during the quarter, compared to analyst estimates of $5.61 billion. Rite Aid had a positive return on equity of 1.66% and a negative net margin of 1.84%. The business's quarterly revenue was up 12.2% compared to the same quarter last year.
View Rite Aid's earnings history.

Shares of Rite Aid reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

3 Wall Street analysts have issued twelve-month price objectives for Rite Aid's stock. Their forecasts range from $17.00 to $18.00. On average, they anticipate Rite Aid's share price to reach $17.50 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts' price targets for Rite Aid.

Media stories about RAD stock have trended extremely negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rite Aid earned a coverage optimism score of -4.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.
View the latest news about Rite Aid.

Rite Aid saw a increase in short interest in January. As of January 15th, there was short interest totaling 17,850,000 shares, an increase of 23.3% from the December 31st total of 14,480,000 shares. Based on an average trading volume of 6,500,000 shares, the days-to-cover ratio is presently 2.7 days. Currently, 33.9% of the company's stock are short sold.
View Rite Aid's Short Interest.

Some companies that are related to Rite Aid include Covetrus (CVET), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ) and General Electric (GE).

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Rite Aid's stock is owned by a number of retail and institutional investors. Top institutional investors include Alberta Investment Management Corp (1.90%), Bank of New York Mellon Corp (0.76%), UBS Group AG (0.50%), California Public Employees Retirement System (0.23%), Swiss National Bank (0.22%) and Goldman Sachs Group Inc. (0.20%).
View institutional ownership trends for Rite Aid.

RAD stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., SeaCrest Wealth Management LLC, World Asset Management Inc, and Mackay Shields LLC.
View insider buying and selling activity for Rite Aid.

RAD stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, MERIAN GLOBAL INVESTORS UK Ltd, Russell Investments Group Ltd., SG Americas Securities LLC, Alberta Investment Management Corp, Strs Ohio, Leap Investments LP, and Bank of New York Mellon Corp.
View insider buying and selling activity for Rite Aid.

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RAD stock can currently be purchased for approximately $14.81.

Rite Aid has a market capitalization of $809.26 million and generates $21.93 billion in revenue each year. The company earns $-452,170,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Rite Aid employs 48,000 workers across the globe.

The official website for Rite Aid is www.riteaid.com.

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]